Page results
-
Emma, our support and information specialist, gives tips to overcome loneliness.
-
The Getting Ready for Transition (GReaT) Group is an interactive workshop for young people with Type I Diabetes, who will be transitioning to secondary school in September, and their parents.
-
Information about having a gadolinium-based contrast agent for MRI examinations while breastfeeding.
-
This page provides information about achalasia and its diagnosis and treatment.
-
This page provides information on Ulcerative Colitis (UC) and how diet can help you manage any symptoms you are managing, improve wellbeing and support a healthy diet during remission.
-
This page provides information on how diet can help to manage the symptoms of Ulcerative Colitis during a flare up known as active Ulcerative Colitis.
-
UCLH is one of the largest blood cancers treatment centres in Europe, with both inpatient beds and a comprehensive day care service. The service is the main treatment centre for patients from north and east London, and west Essex.
-
This page is aimed at providing guidance and recommendations for patients, carers or family members following a high dose examination or procedure performed in the Neuroradiology department at NHNN, which involved ionising radiation.
-
The palliative care team at UCLH provides specialist palliative and end-of-life care to any patient who has a life-limiting illness, and offers support to families and carers.
-
UCLH is the London Cancer Centre for the surgical treatment of prostate cancer.
File results
-
FOI/2023/0560 - Digital maternity training platform
-
FOI/2023/0523 - Treatment on Nivolumab
-
FOI/2023/0537 - Agency usage for the Occupational Therapy
-
FOI/2023/0542 - Pulmonary rehabilitation (PR)
-
FOI/2023/0550 - Varicose veins referrals, treatment and wait time
-
FOI/2023/0553 - Maternity complaints by ethnicity
-
FOI/2023/0559 - Patients admitted to hospital with dental distress
-
FOI/2023/0565 - Rare diseases - diagnosis/ treatment for Fabry/ Gaucher/ Pompe
-
FOI/2023/0569 - Treatment for Ruxolitinib
-
FOI/2023/0566 - Structure chart for IM &T, Business Intelligence, Informatics